Australia's Treasury Minister, Peter Costello has warned that the government needs to controls costs in the Pharmaceutical Benefits Scheme, or face drastic reform in the future. Mr Costello said: "if we're not vigilant, over 20 or 30 years the system we currently operate, which is a good system, could well break." Consumer prices rose in Australia 0.9% in the first quarter of the year, with major rises in drug prices a contributing factor.
In the long run, the Treasurer believes that reforms are inevitable, commenting: "I would be very, very surprised if the system that operates in relation to the PBS today is the system that's operating in Australia in 20 years time."
Mr Costello pointed to an aging population and the emergence of new drug treatments as pushing up the PBS bill. He noted that "new pharmaceuticals are being invented all the time and they're much more expensive. They can treat conditions we couldn't in the past."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze